Suchergebnisse - "Hasegawa, Mayumi"

PubPharm (30)

1

Reply to Béranger et al., "Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children"

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Saito, J. | Shoji, K. | Oho, Y. | +8

CommentOn: Antimicrob Agents Chemother. 2021 Jan 20;65(2):. - PMID 33199385

2

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Saito, J. | Shoji, K. | Oho, Y. | +8

CommentIn: Antimicrob Agents Chemother. 2021 Mar 18;65(4):. - PMID 33495214

3

Benefit-risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers

enthalten in: Cancer science | 2020

von Bei, D. | Osawa, M. | Uemura, S. | +4

ErratumIn: Cancer Sci. 2021 May;112(5):2063. - PMID 33934430

4

Benefit‐risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers

enthalten in: Cancer Science | 2020

von Bei, D. | Osawa, M. | Uemura, S. | +4

5

Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Osawa, M. | Hasegawa, M. | Bello, A. | +2

6

Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Osawa, M. | Hasegawa, M. | Bello, A. | +2

7

Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Osawa, M. | Hasegawa, M. | Bello, A. | +2

8

Population pharmacokinetics analysis of nivolumab in Asian and non-Asian patients with gastric and gastro-esophageal junction cancers

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Osawa, M. | Hasegawa, M. | Bello, A. | +2

9

Estimation of the probability of bacterial population survival : Development of a probability model to describe the variability in time to inactivation of Salmonella enterica

enthalten in: Food microbiology | 2017

von Koyama, K. | Hokunan, H. | Hasegawa, M. | +2

10

Modeling Stochastic Variability in the Numbers of Surviving Salmonella enterica, Enterohemorrhagic Escherichia coli, and Listeria monocytogenes Cells at the Single-Cell Level in a Desiccated Environment

enthalten in: Applied and environmental microbiology | 2017

von Koyama, K. | Hokunan, H. | Hasegawa, M. | +2